Abstract
Allosteric binding sites on adenosine -A1 and -A3 receptors represent attractive therapeutic targets for amplifying, in a spatially and temporally selective manner, the tissue protective actions of endogenous adenosine. This study has directly quantified the kinetics of agonist/G protein-coupled receptor interactions at the single-cell level, reflecting the physiological situation in which intracellular signaling proteins can exert major allosteric effects on agonist-receptor interactions. The association and dissociation rate constants at both A1 and A3 receptors, and therefore the affinity of the fluorescent adenosine derivative ABA-X-BY630 (structure appears in J Med Chem 50:782–793, 2007), were concentration-independent. The equilibrium dissociation constants of ABA-X-BY630 at A1 and A3 receptors were approximately 50 and 10 nM, respectively, suggesting that, even in live cells, low agonist concentrations predominantly detect high-affinity receptor states. At A1 receptors, the dissociation of ABA-X-BY630 (30 nM) was significantly faster in the absence (koff = 1.95 ± 0.09 min−1) compared with the presence of the allosteric enhancer (2-amino-4,5-dimethyl-3-thienyl)(3-(trifluoromethyl)phenyl)-methanone (PD81,723; 10 μM; koff = 0.80 ± 0.03 min−1) and allosteric inhibitor 4-methoxy-N-(7-methyl-3-(2-pyridinyl)-1-isoquinolinyl)benzamide (VUF5455; 1 μM; koff = 1.48 ± 0.16 min−1). In contrast, ABA-X-BY630 dissociation from A3 receptors was significantly slower in the absence (koff = 0.78 ± 0.18 min−1) than in the presence of the allosteric inhibitors VUF5455 (1 μM; koff = 3.15 ± 0.12 min−1) and PD81,723 (10 μM; koff = 2.46 ± 0.18 min−1). An allosteric mechanism of action has previously not been identified for PD81,723 at the A3 receptor or VUF5455 at the A1 receptor. Furthermore, the marked enhancement in fluorescent agonist dissociation by VUF5455 in living cells contrasts previous observations from broken cell preparations and emphasizes the need to study the allosteric regulation of agonist binding in living cells.
Footnotes
This work was supported by the UK Medical Research Council [Grant G0800006]; The University of Nottingham; and a National Health and Medical Research Council of Australia Postdoctoral Fellowship (to L.T.M.).
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.110.064493.
-
ABBREVIATIONS:
- GPCR
- G protein-coupled receptor
- A1AR
- adenosine A1 receptor
- A3AR
- adenosine A3 receptor
- DMEM
- Dulbecco's modified Eagle's medium
- FCS
- fetal calf serum
- ERK
- extracellular signal-regulated kinase
- AM
- acetoxymethyl ester
- ANOVA
- analysis of variance
- CHO
- Chinese hamster ovary
- NECA
- 5′-(N-ethyl carboxamido)adenosine
- CHO-NT
- nontransfected Chinese hamster ovary cells
- DPCPX
- 8-cyclopentyl-1,3-dipropylxanthine
- HBSS
- HEPES-buffered saline solution.
- Received March 4, 2010.
- Accepted June 21, 2010.
- Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|